305 related articles for article (PubMed ID: 8419407)
1. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts.
Funk SE; Sage EH
J Cell Physiol; 1993 Jan; 154(1):53-63. PubMed ID: 8419407
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.
Sage EH; Bassuk JA; Yost JC; Folkman MJ; Lane TF
J Cell Biochem; 1995 Jan; 57(1):127-40. PubMed ID: 7721952
[TBL] [Abstract][Full Text] [Related]
3. SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand.
Murphy-Ullrich JE; Lane TF; Pallero MA; Sage EH
J Cell Biochem; 1995 Feb; 57(2):341-50. PubMed ID: 7539008
[TBL] [Abstract][Full Text] [Related]
4. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells.
Hasselaar P; Sage EH
J Cell Biochem; 1992 Jul; 49(3):272-83. PubMed ID: 1644864
[TBL] [Abstract][Full Text] [Related]
5. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
Basu A; Rodeck U; Prendergast GC; Howe CC
Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
[TBL] [Abstract][Full Text] [Related]
6. The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells.
Funk SE; Sage EH
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2648-52. PubMed ID: 2011576
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of various growth factors and cytokines on the syntheses of DNA, type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in cysteine (SPARC), and alkaline phosphatase by human pulp cells in culture.
Shiba H; Fujita T; Doi N; Nakamura S; Nakanishi K; Takemoto T; Hino T; Noshiro M; Kawamoto T; Kurihara H; Kato Y
J Cell Physiol; 1998 Feb; 174(2):194-205. PubMed ID: 9428806
[TBL] [Abstract][Full Text] [Related]
8. Regulation of human monocyte matrix metalloproteinases by SPARC.
Shankavaram UT; DeWitt DL; Funk SE; Sage EH; Wahl LM
J Cell Physiol; 1997 Dec; 173(3):327-34. PubMed ID: 9369945
[TBL] [Abstract][Full Text] [Related]
9. Effects of basic fibroblast growth factor on proliferation, the expression of osteonectin (SPARC) and alkaline phosphatase, and calcification in cultures of human pulp cells.
Shiba H; Nakamura S; Shirakawa M; Nakanishi K; Okamoto H; Satakeda H; Noshiro M; Kamihagi K; Katayama M; Kato Y
Dev Biol; 1995 Aug; 170(2):457-66. PubMed ID: 7649376
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of extracellular proteins is correlated with angiogenesis in vitro.
Iruela-Arispe ML; Hasselaar P; Sage H
Lab Invest; 1991 Feb; 64(2):174-86. PubMed ID: 1705300
[TBL] [Abstract][Full Text] [Related]
12. Secreted protein acidic and rich in cysteine (SPARC/osteonectin/BM-40) binds to fibrinogen fragments D and E, but not to native fibrinogen.
Wang H; Workman G; Chen S; Barker TH; Ratner BD; Sage EH; Jiang S
Matrix Biol; 2006 Jan; 25(1):20-6. PubMed ID: 16263253
[TBL] [Abstract][Full Text] [Related]
13. Modulation of SPARC expression during butyrate-induced terminal differentiation of cultured human keratinocytes: regulation via a TGF-beta-dependent pathway.
Ford R; Wang G; Jannati P; Adler D; Racanelli P; Higgins PJ; Staiano-Coico L
Exp Cell Res; 1993 Jun; 206(2):261-75. PubMed ID: 8500547
[TBL] [Abstract][Full Text] [Related]
14. Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape.
Lane TF; Sage EH
J Cell Biol; 1990 Dec; 111(6 Pt 2):3065-76. PubMed ID: 2269665
[TBL] [Abstract][Full Text] [Related]
15. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
Francki A; Motamed K; McClure TD; Kaya M; Murri C; Blake DJ; Carbon JG; Sage EH
J Cell Biochem; 2003 Mar; 88(4):802-11. PubMed ID: 12577314
[TBL] [Abstract][Full Text] [Related]
16. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle-dependent nuclear location of the matricellular protein SPARC: association with the nuclear matrix.
Gooden MD; Vernon RB; Bassuk JA; Sage EH
J Cell Biochem; 1999 Aug; 74(2):152-67. PubMed ID: 10404386
[TBL] [Abstract][Full Text] [Related]
18. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
[TBL] [Abstract][Full Text] [Related]
19. Secretion of SPARC by endothelial cells transformed by polyoma middle T oncogene inhibits the growth of normal endothelial cells in vitro.
Sage EH
Biochem Cell Biol; 1992 Jul; 70(7):579-92. PubMed ID: 1449724
[TBL] [Abstract][Full Text] [Related]
20. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
